News in Brief May 13 – Goya, Target and More

Goya Hit with Lawsuit Over Canned Octopus

Goya has been hit with a proposed class action claiming that it’s not being honest about its canned octopus. According to the lawsuit, DNA testing revealed that the “octopus” products were actually made from jumbo squid – which is cheaper and more readily available. The complaint says that the substitution is deceitful because it isn’t mentioned anywhere on the packaging.

FDA Issues Strict Warning Labels for Class of Antibiotics

The U.S. Food and Drug Administration has issued an order to put stronger warnings on a type of antibiotics known as fluoroquinolones. The agency announced that the antibiotics come with inherent risks that usually outweigh the benefits for patients, especially when other treatment options are available. Side effects of fluoroquinolones can potentially cause permanent damage to nerves, muscles, joints, tendons and the central nervous system.

Judge Dismisses Target FCRA Suit

Minnesota federal judge Donovan W. Frank decided to dismiss a class action against Target. The suit claimed that Target violated the Fair Credit Reporting Act by including irrelevant information in its employee background check notifications. Frank reasoned that even if Target violated the FCRA, the court couldn’t conclude that the violation was deliberate.

Bloomberg Settles Wage and Hour Lawsuit

Bloomberg has agreed to pay $5.5 million to settle accusations that it underpaid its New York call center employees. The proposed class action claimed that Bloomberg failed to pay its workers for meal breaks and work done after their shifts ended. Up to 160 Bloomberg employees in New York will be able to claim a part of the settlement.